3M (MMM) Morgan Stanley 12th Annual Laguna Conference summary

Financial performance and outlook

• Adjusted earnings per share up 38% in the first half, with organic revenue growth at 1% and $2B in free cash flow, 83% conversion ratio.

• Raised earnings per share guidance to $7.00-$7.30, representing 16%-21% adjusted growth for the year; organic growth expected at 0%-2%.

• Margin performance strong, with 500 basis points improvement in the first half and full-year guidance up 225-275 basis points; operating margin expected at 21%-21.5%.

• Restructuring program 75% complete, expected to provide tailwinds to margins next year as cost savings materialize.

• Gross margin at 44% in the first half, with a goal to return to high 40s over time through productivity and supply chain improvements.

Strategic priorities and operational focus

• Three main priorities: reinvigorating top-line growth, driving operational performance, and effective capital deployment.

• Emphasis on innovation, commercial excellence, and supply chain/logistics improvements across the enterprise.

• Capital deployment focused on organic investment (CapEx, R&D), maintaining dividends, and using excess cash for buybacks or M&A.

• Internal culture shift underway, encouraging employees to challenge the status quo and focus on value creation.

• Operational excellence initiatives are ongoing, not one-time events, with a focus on continuous improvement (Kaizen).

Growth, R&D, and portfolio management

• R&D spend has been flat in nominal terms and declining in real terms; new product development as a share of R&D spend has dropped below 30%.

• Number of new product introductions has declined significantly over the past decade; efforts underway to correct this and increase innovation velocity.

• Portfolio review ongoing, with a focus on technology-driven differentiation; potential for future portfolio shifts to align with innovation strengths.

• R&D and innovation identified as essential for returning to above-GDP organic growth; vitality index has dropped to low double digits.

• Opportunities to optimize SG&A and R&D spending to support growth without sacrificing margin expansion.